Project Grant HT94252510952
Award Date 9/1/25
Completion Date 8/31/26
Dollars Obligated $158K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90024, USA
Similar Awards
- This federal Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) provides $1,659,679.00 in funding to the University of California, Los Angeles (UCLA) to conduct research targeting heterogeneity in NF2-mutant tumors. The award period runs from September 15, 2024 through September 14, 2027. The key products and services to be delivered under this grant include innovative scientific research, laboratory studies, and...
- This federal Project Grant award of $523,614.37, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research into the genetic mechanisms underlying schwannomatosis and other rare conditions. The University of Manchester, a prominent research institution in the United Kingdom, will conduct this 3-year research initiative, focusing on elucidating the disease-specific genetic factors that distinguish...
- This Project Grant award of $1,257,982.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by the University of California, San Francisco (UCSF) to map the RNA splicing landscape of NF1 and its impact on neurofibromin function across tissues. The research aims to transform healthcare for military service members, veterans, and the general public by developing innovative medical solutions to address critical health...
- This $165,000 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research conducted by the Massachusetts General Hospital to map drug-sensitive gene expression profiles to spatial patterns of heterogeneity in a mouse model of schwannoma. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing scientific understanding and developing potential...
- This federal Project Grant award of $158,500.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the development of a genetically engineered mouse model of spinal ependymoma precursors in NF2-related schwannomatosis. The project will be conducted by the Trustees of Indiana University, a prominent public research university, over a performance period from September 15, 2025 to August 14, 2027. The award aims to advance biomedical research...
- The Department of the Army Medical Command awarded a $161,500 Project Grant to The Regents of the University of California, San Francisco to support research investigating the mechanisms and consequences of Hedgehog signaling and immune infiltration in schwannoma. The award period is from July 15, 2021 through July 14, 2023. The research is being conducted under the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health through...
- The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
- The Project Grant award of $649,000.00 from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to Rutgers, The State University of New Jersey will support research to characterize the oncogenic transcriptional activation during the malignant transformation of NF1 nerve sheath tumors. The award period runs from August 1, 2025 to July 31, 2028. This research aims to advance the scientific understanding of the genetic and molecular mechanisms underlying...
- The Defense Health Agency awarded a $847,875 Project Grant to the Rector & Visitors of the University of Virginia (UVA) under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "Targeting Schwann Cell-Tumor Microenvironment Interactions in Neurofibroma Development," supports advanced biomedical research to transform healthcare for military service members, veterans, and the public. The research project at UVA aims to investigate the cellular...
- This federal Project Grant award of $155,500.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research at The Washington University in University City, Missouri. The research project is focused on investigating the "Pathophysiologic Effects of Obesogenic Diet in Neurofibromatosis Type 1 and Impact on Tumor Formation". The 2-year project period runs from September 30, 2025 to September 29, 2027 and aims to...